PROVIDENCE – CVS Health Corp. has agreed to pay $37.76 million to settle claims it improperly overdispensed and overbilled federal health care programs for insulin pens between 2010 and 2020, according to a report by Reuters. The settlement, announced by U.S. Attorney Jay Clayton in Manhattan on Dec. 2, resolves the accusation by the U.S.
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
- Critical RI business news and analysis updated daily.
- 1 year of print (26 issues).
- Unlimited access to all subscriber only content on our website, on any device.
- Free email alerts.
- Annual Book of Lists Print Edition.
- All special issues produced during subscription term.
Click Here to purchase a paywall bypass link for this article
PBN Branded Content
Facing the Holidays with a Cancer Diagnosis
The holidays are often painted as a time of joy, tradition, and togetherness. But for…
Learn More
